191 – 200 of 396
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
CGRP receptor antagonism and migraine.
(
- Contribution to journal › Article
-
Mark
NF-kappaB signaling mediates vascular smooth muscle endothelin type B receptor expression in resistance arteries.
(
- Contribution to journal › Article
-
Mark
Possible sites of action of the new calcitonin gene-related peptide receptor antagonists.
(
- Contribution to journal › Article
-
Mark
Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway.
(
- Contribution to journal › Article
-
Mark
Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries.
(
- Contribution to journal › Article
-
Mark
Increased Tissue Endothelin-1 and Endothelin-B Receptor Expression in Temporal Arteries from Patients with Giant Cell Arteritis.
(
- Contribution to journal › Article
-
Mark
Subarachnoid Hemorrhage Induces Enhanced Expression of Thromboxane A(2) Receptors in Rat Cerebral Arteries.
(
- Contribution to journal › Article
-
Mark
New drugs in migraine treatment and prophylaxis: telcagepant and topiramate.
(
- Contribution to journal › Article
-
Mark
Cigarette Smoke Extracts Promote Vascular Smooth Muscle Cell Proliferation and Enhances Contractile Responses in the Vasculature and Airway.
(
- Contribution to journal › Article
- 2009
-
Mark
Increased expression of endothelin ETB and angiotensin AT(1) receptors in peripheral resistance arteries of patients with suspected acute coronary syndrome
(
- Contribution to journal › Article